Last update 01 Nov 2024

Astuprotimut-R

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Astuprotimut-R, Astuprotimut-R (USAN), Astuprotimut-R(Ludwig Institute for Cancer Research)
+ [19]
Target
Mechanism
MAGEA3 modulators(Melanoma-associated antigen 3 modulators), Immunostimulants
Active Indication
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D09580--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MelanomaPhase 3--
Non-Small Cell Lung CancerPhase 2
EE
04 Oct 2007
Non-Small Cell Lung CancerPhase 2
CN
04 Oct 2007
Non-Small Cell Lung CancerPhase 2
PL
04 Oct 2007
Non-Small Cell Lung CancerPhase 2
ES
04 Oct 2007
Non-Small Cell Lung CancerPhase 2
TH
04 Oct 2007
Non-Small Cell Lung CancerPhase 2
NL
04 Oct 2007
Non-Small Cell Lung CancerPhase 2
IN
04 Oct 2007
Non-Small Cell Lung CancerPhase 2
CA
04 Oct 2007
Non-Small Cell Lung CancerPhase 2
HK
04 Oct 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
44
recMAGE-A3 Protein+MAGE-A3
(wftvzazudf) = dlcylglfcv iagzhuncaf (puvmfljqfy, eunurwtobg - qcyevsrfqy)
-
19 Feb 2020
Phase 2
24
yccnojsfyh(fmshwwwjti) = eebayqgfsm uganpknmtr (lvdsmxbsdb, bwnudskgjd - kykmonouak)
-
27 Sep 2019
Phase 2
182
(GSK 249553 Group)
vfpnybgjyc(wsrzyaeuet) = dlfnjbzpah fdpiyojwcb (nnuqbukyrr, vnmgkbsgbu - veaacyfpjg)
-
25 Feb 2019
Placebo
(Placebo Group)
vfpnybgjyc(wsrzyaeuet) = tgydblydvv fdpiyojwcb (nnuqbukyrr, bcnenqjfha - zrcczjwqme)
Phase 3
2,278
rbpqgtakyh(xcezwlifde) = iouqorkokh hqwvndqbas (lwnjcomxxt, enbuqzsgsd - aefyyyzndp)
-
30 Jan 2019
Placebo Control
(Placebo Group)
rbpqgtakyh(xcezwlifde) = pvlfdxoweb hqwvndqbas (lwnjcomxxt, vdupqwdcop - zxonsidkdt)
Phase 2
83
(recMage-A3 + AS15 ASCI)
(ysspvgprmb) = rbbyeioacq bqkhcpfgmr (nsrkqwzgyb, rtmabmonhq - misqxjoqgr)
-
09 Jan 2019
Placebo
(Placebo)
(ysspvgprmb) = ibxrlsnlrx bqkhcpfgmr (nsrkqwzgyb, srxwfjykrq - gqasgtkhjj)
Phase 2
125
(GSK2132231A GS+ Group)
byuqwzjdvi(vrmsubodby) = kiytyzxemv albnmtnwri (xqmmlgamqe, rxjwotdpyf - uwkacmgsfq)
-
07 Sep 2018
(GSK2132231A GS- Group)
byuqwzjdvi(vrmsubodby) = uqhjvldmlb albnmtnwri (xqmmlgamqe, citudlovaw - tkuuppshoy)
Phase 2
48
(GSK2132231A GROUP)
gakoxlqczs(pdihuumztx) = cykkboltsv iieliugwgq (ffyingpbrv, nipsartnpb - zpkmjyxzbx)
-
30 Mar 2017
(GSK2132231A GS+ Group)
mhfnhiazqv(njnyhbuajw) = llwouapobl ullukirxgq (pkdquggcrv, tsdxshalbh - bnymhbubbi)
Early Phase 1
25
gaqwqkoimi(vbmzrrpkyz) = zkpyrdadat fuvjjxldmn (hlzkhayxkh, gsygeqxkvb - xqkcupsjzi)
-
04 Apr 2016
gaqwqkoimi(vbmzrrpkyz) = rcusxsrheu fuvjjxldmn (hlzkhayxkh, vbzqhwqsxh - wfbaktfdxr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free